Management of Acute Alcohol Withdrawal

Benzodiazepine Selection

The American Association for the Study of Liver Diseases recommends diazepam or chlordiazepoxide for patients with normal liver function due to their long half-life and excellent protection against seizures and delirium tremens 1
For patients with impaired liver function, the American Association for the Study of Liver Diseases suggests lorazepam due to its simpler metabolism and less accumulation 2
The European Association for the Study of the Liver recommends lorazepam for elderly patients or those with severe liver dysfunction 3

The American College of Gastroenterology recommends using symptom-triggered dosing rather than a fixed schedule to prevent drug accumulation while ensuring adequate symptom control 3
The Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scale is recommended to monitor withdrawal severity, with treatment initiation when the score exceeds 8 and intensification when the score reaches 15 3
The American College of Gastroenterology advises limiting benzodiazepine treatment to 10-14 days to avoid dependence risk 3

The American Gastroenterological Association recommends administering thiamine (100-300 mg/day) to all patients with alcohol withdrawal to prevent Wernicke's encephalopathy 2
Adequate hydration and electrolyte replacement, especially magnesium, are recommended by the European Association for the Study of the Liver 2

For patients with decompensated liver disease, the European Association for the Study of the Liver suggests using symptom-adapted dosing and favoring short-acting benzodiazepines like lorazepam 4
Inpatient treatment is recommended by the American Association for the Study of Liver Diseases for patients with severe withdrawal symptoms, history of withdrawal seizures or delirium tremens, or serious medical/psychiatric comorbidities 2